EP2844220
Lyfjasamsetning með seinkaða losun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.4.2013EP published:
23.1.2019EP application number:
13719543.4
EP translation filed:
12.3.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
28.4.2033Expiry date:
28.4.2026Next due date:
30.4.2026
Title:
A DELAYED RELEASE DRUG FORMULATION
Timeline
Today
29.4.2013EP application
23.1.2019EP Publication
12.3.2019Translation submitted
15.4.2019Registration published
28.4.2026Expires
Owner
Name:
TILLOTTS PHARMA AGAddress:
Baslerstrasse 15, 4310, Rheinfelden, CH
Inventor
Name:
BRAVO GONZÁLEZ, Roberto CarlosAddress:
Binningen, CH
Name:
BUSER, ThomasAddress:
Nuglar, CH
Name:
GOUTTE, Frédéric Jean-ClaudeAddress:
Schwoben, FR
Name:
BASIT, Abdul, WasehAddress:
HarrowMiddlesex HA3 8JB, GB
Name:
VARUM, Felipe, José, OliveiraAddress:
Riehen, CH
Name:
FREIRE, Ana,CristinaAddress:
NorthamptonNN4 8BY, GB
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
12166110Date:
30.4.2012Country:
EP
Number:
201261640217 PDate:
30.4.2012Country:
US
Classification
Categories:
A61K 9/00, A61K 9/28, A61K 31/606, A61K 47/32, A61K 47/36, A61K 31/196, A61K 31/616
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.4.2019
Expires: 28.4.2020
Payer: Árnason Faktor
Number: 8
Paid: 10.3.2020
Expires: 28.4.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 10.3.2021
Expires: 28.4.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.3.2022
Expires: 28.4.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.3.2023
Expires: 28.4.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.3.2024
Expires: 28.4.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 18.3.2025
Expires: 28.4.2026
Payer: Árnason Faktor ehf.